0001209191-21-023758.txt : 20210331 0001209191-21-023758.hdr.sgml : 20210331 20210331160207 ACCESSION NUMBER: 0001209191-21-023758 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200706 FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMAN STEVEN C CENTRAL INDEX KEY: 0001379970 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 21793172 MAIL ADDRESS: STREET 1: 110 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562181648 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-07-06 2020-07-06 0 0001178253 SCYNEXIS INC SCYX 0001379970 GILMAN STEVEN C 1 EVERTRUST PLAZA, 13TH FLOOR JERSEY CITY NJ 07302-6548 1 0 0 0 Stock Option (Right to Buy) 0.73 2020-07-06 4 A 0 55000 0.00 A 2030-07-05 Common Stock 55000 55000 D One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. This Form 4/A is being filed only to correct the number of shares subject to the stock option acquired by the Reporting Person, which was originally reported to have been 45,000 on 7/6/2020 but was 55,000. Subsequent to the date of grant, the Issuer effected a 1-for-10 reverse stock split and, accordingly, this stock option has become an option to acquire 5,500 shares with an exercise price of $7.30 per share. /s/ Robert F. Joyce Jr., by Power of Attorney 2021-03-31